April 16, 2012
The University of California, San Diego and the Arthur C. Clarke Foundation have agreed to establish the Arthur C. Clarke Center for Human Imagination (ACCCHI) at UC San Diego. The agreement was signed in conjunction with the foundation’s annual international Clarke Awards held on April 12 in Washington, D.C.
March 16, 2021
Since 2009, Daniel Tward and his collaborators at UCLA and Johns Hopkins University have analyzed more than 47,000 images of human brains via MRI Cloud—a gateway created to collect and share quantitative information from human brain images, including subtle changes in shape and cortical thickness.
January 23, 2023
Researchers at University of California San Diego and UC Riverside have further elucidated the molecular pathway used by the SARS-CoV-2 virus to infect human lung cells, identifying a key host-cell player that may prove a new and enduring therapeutic target for treating COVID-19.
January 16, 2024
A vaccine for Staphylococcus aureus, one of the most common bacterial infections, would be a game changer for public health. No vaccine candidates have succeeded in clinical trials, but nobody knows why. Researchers at UC San Diego may have figured it out.
February 22, 2021
Researchers at UC San Diego School of Medicine use bacteriotherapy to improve symptoms of atopic dermatitis.
August 28, 2017
…the San Diego Veterans Administration Medical Center report that human neural stem cells (NSCs) grafted into spinal cord injuries in laboratory rats displayed continued growth and maturity, with functional recovery beginning one year after grafting.
April 28, 2021
UC San Diego School of Medicine researchers discovered one way in which SARS-CoV-2 hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause disease.
December 12, 2018
UC San Diego researchers join national effort to better understand human immune system as part of new Allen Institute of Immunology.
September 18, 2013
University of California, San Diego bioengineering professor Gert Cauwenberghs has been selected by the National Science Foundation to take part in a five-year, multi-institutional, $10 million research project to develop a computer vision system that will approach or exceed the capabilities and efficiencies of human vision.
September 9, 2014
Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.
